Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subjects: Conference, Event, Trade Show, Webcast

Aldeyra to Present at Cantor and H.C. Wainwright Virtual Investor Conferences


Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that senior management will be presenting and hosting one-on-one meetings at the following investor conferences:

A live webcast of the presentations will be available on the investor relations page of the company's corporate website at https://ir.aldeyra.com. After the live webcast, the events will remain archived on the Aldeyra Therapeutics website for 90 days.

About Aldeyra Therapeutics

Aldeyra Therapeutics is a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with immune-mediated diseases. Two of the company's lead compounds, reproxalap and ADX-629, target reactive aldehyde species (RASP), which are elevated in ocular and systemic inflammatory disease and result in cytokine release via activation of a broad array of inflammatory factors, including NF-?B, inflammasomes, and Scavenger Receptor A. Reproxalap is being evaluated in Phase 3 clinical trials in patients with dry eye disease and allergic conjunctivitis. The company's clinical pipeline also includes ADX-2191, a dihydrofolate reductase inhibitor in Phase 3 testing for proliferative vitreoretinopathy, and ADX-1612, a chaperome inhibitor in development for COVID-19 and ovarian cancer. For more information, visit https://www.aldeyra.com/ and follow us on LinkedIn, Facebook, and Twitter.


These press releases may also interest you

at 15:10
The Canadian Red Cross has launched a nationwide recruitment campaign seeking Canadians who want to make a difference during the COVID-19 pandemic, and beyond. The Red Cross anticipates the need for assistance to increase across sectors as the...

at 15:10
Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, today announced that, for the second year in a row, Science magazine has named the company a top employer in its annual survey of the biotech and pharmaceutical industry. "We are...

at 15:03
Spherix recently surveyed 103 US gastroenterologists and followed up with ten qualitative interviews (including two with industry key opinion leaders) in order to assess the current and future treatment paradigm of eosinophilic esophagitis (EoE)...

at 15:01
Recruitment is underway for volunteers for the phase 3 trial of the Oxford University ? AstraZeneca COVID-19 vaccine at UCLA Health which joins other medical centers nationwide as part of the study effort . The vaccine, developed by Oxford University...

at 15:00
AGC Biologics, a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced that its partnership with Horizon Therapeutics plc is expanding to produce Horizon's Thyroid Eye Disease (TED) treatment,...

at 15:00
The "Global Next-Generation Surgical Robotics Market: Analysis and Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering. The market size of next-generation surgical robotics was valued at $10.9 million in 2019. The global...



News published on 10 september 2020 at 08:10 and distributed by: